Related Experiment Video
Updated: Oct 24, 2025

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
Published on: November 17, 2017
Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?-Lessons learned through the
S Sankha Datta1, R Chakrabarty2
1Department of Transfusion Medicine, Tata Medical Center, Newtown, Rajarhat, Kolkata Pin-700160, India.
India has literally been devastated by the second wave of the Covid-19. Convalescent plasma (CP) therapy which was approved initially for Covid-19 in India has been recently excluded from the Covid-19 management protocol. Herein we would like to explore the major challenges for CP therapy in India that we observed during the current pandemic.
India has literally been devastated by the second wave of the Covid-19. Convalescent plasma (CP) therapy which was approved initially for Covid-19 in India has been recently excluded from the Covid-19 management protocol. Herein we would like to explore the major challenges for CP therapy in India that we observed during the current pandemic.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Myocarditis III: Medical Management

